Palbinone alleviates diabetic retinopathy in STZ‐induced rats by inhibiting NLRP3 inflammatory activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Palbinone alleviates diabetic retinopathy in STZ‐induced rats by inhibiting NLRP3 inflammatory activity

Published:2020-03-22 Issue:7 Volume:34 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem Mol Toxicol

Author:

Shi Qiang¹^ORCID,Wang Jianchao²,Cheng Yuhong¹,Dong Xiaomin¹,Zhang Ming¹,Pei Cheng¹

Affiliation:

1. Department OphthalmologyThe First Affiliated Hospital of Xi'an Jiao Tong University Xi'an China

2. Department OpthalmologyThe Second Affiliated Hospital of Xi'an Jiao Tong University Xi'an China

Funder

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22489

Reference31 articles.

1. The current state of diabetes mellitus in India

2. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

3. Diabetic retinopathy

4. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

5. Diabetic Retinopathy: Vascular and Inflammatory Disease

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic efficacy and pharmacological mechanism of Guizhi Fuling Pill on ischemic stroke: a meta-analysis and network pharmacology analysis;Metabolic Brain Disease;2024-07-25

2. The Role of Natural Products in Diabetic Retinopathy;Biomedicines;2024-05-21

3. Molecules and targets of antidiabetic interest;Phytomedicine Plus;2024-02

4. Exploring the Therapeutic Efficacy and Pharmacological Mechanism of Guizhi Fuling Pills on Ischemic Stroke: A Meta-Analysis and Network Pharmacology Analysis;2023-12-23

5. Drugs Targeting NLRP3 Inflammasome in the Treatment of Diabetic Bone Disorders;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3